The immunopharmacology of antileprosy agents.
D000942:Antigens, Bacterial / Q000276:immunology; D002991:Clofazimine / Q000494:pharmacology; D003622:Dapsone / Q000494:pharmacology; D004893:Erythema Nodosum / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular / Q000187:drug effects; D007917:Leprostatic Agents / Q000494:pharmacology*; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology; D008213:Lymphocyte Activation; D009166:Mycobacterium leprae / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D012293:Rifampin / Q000494:pharmacology
D000942:Antigens, Bacterial; D007917:Leprostatic Agents; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin